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Background: Chronic idiopathic urticaria (CIU) has a significant impact on patients’ quality of life.
Objective: The purpose of this study is to assess that impact and to compare differences by culture, gender, age or duration of 
treatment.
Methods: We used the modified chronic urticaria quality of life questionnaire, consisting of 15 questions. Over the course of 6 
months, patients attending Immunology clinics at Campbelltown Hospital and private rooms in Australia and at the faculty of 
Medicine, University of Kelaniya in Sri Lanka were asked to fill out the questionnaires. We have obtained the data from 125 patients 
(43 Australian vs. 82 Sri Lankan). There were significantly more female patients (p < 0.01). The data was analysed using SAS.
Results: Overall, patients were affected mostly by itch and wheals and least affected by the side effects of treatments. Sri Lankan 
populations were more affected by wheals and by interference on activities, mood and food choices but were less affected by 
tiredness due to sleep disturbances (p < 0.01). Females were more affected by sleep disturbance (p < 0.05) while those older than 40 
years of age were more impacted by tiredness and by the side effects from medications (p < 0.05), though the complaints themselves 
were mild. Those who suffered from CIU for more than 1 year were more affected by wheal, tiredness and irritability (p ≤ 0.05).
Conclusion: The questionnaire highlighted some differences between patients attending Australian versus Sri Lankan outpatients. 
Significant differences were found in one third of parameters which include mood, sleep, daily activities and food choices.
Key words: Chronic urticaria; Quality of life; Australian population; Sri Lankan population; Cultural differences
Correspondence: Constance H. Katelaris
Campbelltown Hospital, Campbelltown NSW 2560, Australia
Tel: +61-2-4634-3000
Fax: +61-2-4634-3000      
E-mail: chk@allergyimmunol.com.au
Received: January 29, 2011
Accepted: February 23, 2011
This is an Open Access article distributed under the terms of the Creative 
Commons Attribution Non-Commercial License (http://creativecommons.
org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, 
distribution, and reproduction in any medium, provided the original work is 
properly cited.
Copyright © 2011. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. 
http://apallergy.org
INTRODUCTION
Chronic idiopathic urticaria (CIU) is a common condition, 
affecting 0.1% of the general population [1]. It is not life-
threatening but several studies over the last decade have shown 
that it has a significant impact on quality of life (QoL) [2-4]. Its 
effect on QoL is comparable to that experienced by patients 
suffering from ischaemic heart disease with considerable loss of 
energy, sleep disturbance and emotional upset [2]. Compared to 
QoL in patients with respiratory allergy, CIU patients were more 
affected in physical functioning, pain perception and perceived 
health [3]. Compared to other dermatological conditions, the 
overall impact of CIU on QoL can be likened to acne and psoriasis 
[4]. More specifically, its physical discomfort and effect on daily apallergy.org
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living activities are similar to those suffering from atopic dermatitis 
and are more severe than psoriasis [5].
Despite these facts, there are only a few studies that have 
specifically looked at QoL in CIU. This is particularly relevant 
given the primary goal of CIU treatment is symptom control and 
improvement in QoL. As patient perception of disease and QoL 
can vary in different cultural contexts, understanding particular 
aspects of QoL specific to a given culture may bring into focus 
areas that need greater attention. However, there is no study to 
our knowledge that has compared QoL in CIU in different cultural 
contexts.
Most of the studies done so far have used different types of 
questionnaires with a varying degree of specific questions for 
CIU. Generic tools such as SF-36 (a health status questionnaire) 
and Nottingham Health Profile have the advantage of allowing 
comparison with different conditions but they have a potential 
to underestimate specific aspects of QoL that are particularly 
affected by CIU. Two other studies comparing QoL in CIU vs. other 
dermatological conditions have employed either the dermatology 
life quality index (DLQI) or VQ-Dermato [4, 5].
 DLQI has been used 
extensively in assessment of dermatological conditions with good 
internal consistency and reliability. It has the advantage of being 
more relevant to dermatological conditions while allowing it to 
compare CIU with other dermatological diseases but again, it is 
not specifically developed for CIU. Recently a new tool, chronic 
urticaria quality of life questionnaire (CU-Q2oL), has been devised 
with a good level of validity, internal consistency and reliability [6]. 
It is able to evaluate the specific QoL issues related to CIU and at 
the same time, it is simple to administer, taking only a few minutes 
to complete.
The purpose of this study is to assess the impact of CIU on QoL 
and to compare the differences in different cultural contexts, in 
particular, in Australian and Sri Lankan populations. It also looks at 
whether gender, age or the duration of treatment have any impact 
on QoL. As this study is looking at the QoL in the same disease but 
in different subgroups, it was felt that administering CU-Q2oL was 
more appropriate for the reasons outline above.
METERIALS AND METHODS
Subjects
In the first half of 2008, patients with the diagnosis of CIU 
attending either public or private Immunology/Allergy Clinics 
in Sydney, Australia and the clinic in the faculty of Medicine, 
University of Kelaniya in Sri Lanka were asked to fill out the 
questionnaire. Diagnosis of CIU was made based on history and 
examination by attending specialists. 
Questionnaire
  1.  Are you affected by itch?
  2.  Are you affected by wheals (welts)?
  3.  Are you affected by swelling (e.g. of lips or eyes)?
  4.  Urticaria interferes with my regular activities at home and at work
  5.  Urticaria interferes with my recreational activities.
  6.  Does urticaria affect your sleep?
  7.  Do you have difficulty falling asleep?
  8.  Do you feel tired during the day because of your bad night sleep?
  9.  Does urticaria affect your mood?
10.  Are you feeling irritable because of your symptoms?
11.  Do you feel embarrassed because of your condition?
12.  Are you embarrassed to go into public places?
13.  Do you put limits on your food choices because of urticaria?
14.  Do you put limits on your physical activity because of urticaria?
15.  Are you affected by side effects from your medication?
Fig. 1. The self-administered questionnaire had four sections; personal 
details, practical problems, activities and mood. Respondents answered 
questions in the practical problems, activities and mood sections by 
selecting one of seven responses: not affected (score = 0), hardly affected 
at all (1), slightly affected (2), moderately affected (3), quite a bit affected 
(4), very affected (5) or extremely affected (6). 
Table 1. Sample characteristics
      n (%) Chi-square 
p-value
Nationality
      Australian   43 (34.4)
      Sri Lankan   82 (65.6)
Sex
      Male   42 (33.6)
 <0.01
      Female   83 (66.4)
Age
      ≤ 40 years   61 (48.8)
  0.13 
      > 40 years   64 (51.2)
Duration
     ≤ 1 year   47 (37.6)
   0.32        > 1 year   75 (60.0)
     Data not available   3 (2.4)
Treatment
      Off   7 (5.6)
<0.01
      On 118 (94.4)
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Questionnaire instruments
We have used the CU-Q2oL published by Baiardini et al. [6]
 
with modifications
. (Fig. 1). A question on irritability was added 
as previous studies have indicated that CIU affects emotions and 
that this aspect needs to be explored further [2-5]. The questions 
on the use of cosmetics and limitations in choosing clothing 
materials were omitted as they were considered less relevant in 
our study populations. Indeed, in the original article by Baiardini 
et al. [6], these two questions ranked low in the overall impact. In 
addition, a question on nocturnal waking was also removed as 
there were already three questions pertaining to the effect of sleep 
disturbances. The questions on urticaria interfering with spare time 
and with social relationship were combined to form a question 
on recreational activities. The scales were increased from 0-3 to 
0-6 as we felt that 0-3 scale would not capture varying degrees of 
discomfort experienced by patients. Score 0 was given when the 
patient was not affected and 6 was given when the patient was 
extremely affected. 
Statistical analysis
Data was analysed using SAS version 9.1.3 (SAS Institute, USA). 
Non-parametric statistical methods were used as normality was 
not accepted within groups. Hence median rather than mean 
values were used to determine p-values although parametric 
tests returned similar p-values and reached the same conclusions 
anyway. A non-parametric alternative to a two sample t-test, 
Wilcoxon Mann-Whitney test, was used to ascertain significant 
differences. p-values ≤0.05 was considered statistically significant.
RESULTS
Demographics. Table 1 summarises the characteristics of the 
two study populations.
Questionnaire results. Overall, pruritus (median 5, mean 4.2) and 
wheals (median 5, mean 3.8) were the commonest complaints 
followed by CIU interfering with regular activities (median 4, mean 
3.4), recreational activities (median 3, mean 3.1) and mood (median 
3, mean 3.1). Patients were least affected by the side effects of 
treatments (median 0, mean 1.3) (Table 2, mean data not shown).
There were statistically significant differences noted between 
Australian and Sri Lankan patients in 5 out of 15 questions. The Sri 
Lankan population was more affected by wheals (median 5 vs. 4, 
p = 0.01) and by its interferences with regular activities (median 4 
vs. 3, p < 0.01), mood (median 4 vs. 2, p < 0.01) and food choices 
(median 3 vs. 1, p < 0.01) but were less affected by tiredness due 
to sleep disturbances (median 1 vs. 3, p < 0.01) when compared to 
the Australian population (Table 2).
Table 2. Median modified CU-Q2oL scores by nationality
Australian Sri Lankan p-value Total 
Practical problems
  Are you affected by itch? 5.0 5.0 0.71 5.0
  Are you affected by wheals (welts)? 4.0 5.0 0.01 5.0
  Are you affected by swelling (e.g. of lips or eyes)? 2.0 3.0 0.99 3.0
Activities
  Urticaria interferes with my regular activities at home or at work 3.0 4.0 < 0.01 4.0
  Urticaria interferes with my recreational activities 3.0 4.0 0.08 3.0
  Does urticaria affect your sleep? 3.0 3.0 0.81 3.0
  Do you have difficulty falling asleep? 3.0 1.0 0.14 1.5
  Do you feel tired during the day because of your bad night sleep? 3.0 1.0 < 0.01 1.0
Mood
  Does urticaria affect your mood? 2.0 4.0 < 0.01 3.0
  Are you feeling irritable because of your symptoms? 3.0 4.0 0.69 3.0
  Do you feel embarrassed because of your condition? 3.0 1.0 0.13 2.0
  Are you embarrassed to go into public places? 2.0 1.0 0.42 1.0
  Do you put limits on your food choices because of urticaria? 1.0 3.0 < 0.01 3.0
  Do you have limits on your physical activity because of urticaria? 1.0 0.0 0.36 0.0
  Are you affected by side effects from your medications? 1.0 0.0 0.28 0.0
CU-Q2oL: chronic urticaria quality of life questionnaire.apallergy.org
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Females were more affected in sleep, especially with difficulty 
falling asleep (median 2 vs. 1, p < 0.05) but there were no 
differences in other parameters (Table 3). Those older than 40 years 
of age were more affected by tiredness due to poor sleep (median 
2 vs. 1, p < 0.05) and by the side effects of medications (median 1 
vs. 0, p < 0.05) though the complaints were mild. Patients who had 
CIU for longer than 1 year were more affected by itch (median 5 vs. 
4, p = 0.01), tiredness due to poor sleep (median 2 vs. 1, p < 0.05) 
and irritability (4 vs. 2.5, p = 0.05). 
DISCUSSION
Previous studies [2, 5] have indicated that CIU has a significant 
impact on QoL with notable effects on sleep, energy levels and 
mood so it is not surprising that the present study revealed similar 
results. The Australian patient population reported more sleep 
disturbance leading to daytime tiredness when compared to 
the Sri Lankan population but in both groups, those with longer 
duration of CIU reported more sleep disturbance, tiredness ands 
irritability.
Sri Lankan patients were more affected by wheals than 
their Australian counterparts. The reason for this is unclear and 
somewhat surprising as urticaria is usually less visible on darker skin. 
Cultural perception does not seem to play a major role in this as 
there was no significant difference in the level of embarrassment. 
Warmer climate in Sri Lanka may account for worsening wheals as 
urticaria is often exacerbated by heat. However, this alone does not 
provide an adequate explanation as other parameters such as itch 
were not increased. Alternatively, higher prevalence of helminth 
infections in Sri Lankan population with subsequent higher total 
IgE levels may play a role in worsening wheal formation. While 
there are reports of CIU associated with helminth infections, 
further studies will be required to clarify this issue [7, 8]. Sri Lankan 
patients were also more impacted by interference with regular 
activities and mood. The reasons for these are not apparent.
Sri Lankan populations were more inclined to limit food choices 
when compared to Australian patients. This may be due to a more 
prevalent assumption that CIU is due to food hypersensitivity in Sri 
Lanka. Alternatively, avoidance of certain common spicy foods in 
Sri Lanka that result in worsening symptoms by increasing body 
temperature may explain this phenomenon. While a number 
of significant differences in QoL parameters have been seen in 
this comparative study between two cultural groups, there are 
some potential confounders to be addressed. Firstly, there was no 
attempt to rank the severity of each patient’s CIU. Thus it is possible 
Table 3. Median modified CU-Q2oL scores by different subgroups
Gender Age Duration of CU
Male Female p-value ≤ 40 
years
> 40 
years p-value ≤ 1 year > 1 year p-value
Practical problems
Are you affected by itch? 4.0 5.0 0.38 4.0 5.0 0.25 4.0 5.0 0.01
Are you affected by wheals (welts)? 5.0 4.5 0.56 4.0 5.0 0.53 4.0 5.0 0.22
Are you affected by swelling (e.g. of lips or eyes)? 2.0 3.0 0.16 2.0 3.5 0.14 3.0 3.0 0.26
Activities
Urticaria interferes with my regular activities at home or at work 4.0 4.0 0.29 4.0 4.0 0.86 3.0 4.0 0.38
Urticaria interferes with my recreational activities 3.0 3.0 0.67 3.0 3.0 0.74 3.0 4.0 0.24
Does urticaria affect your sleep? 2.0 3.0 0.06 2.5 3.0 0.52 1.5 3.0 0.06
Do you have difficulty falling asleep? 1.0 2.0 0.04 1.0 2.0 0.17 1.0 2.0 0.20
Do you feel tired during the day because of your bad night sleep? 1.0 2.0 0.12 1.0 2.0 0.03 1.0 2.0 0.02
Mood
Does urticaria affect your mood? 2.0 3.0 0.61 3.0 3.0 0.37 3.0 3.0 0.39
Are you feeling irritable because of your symptoms? 3.0 3.0 0.70 3.0 3.0 0.24 2.5 4.0 0.05
Do you feel embarrassed because of your condition? 1.0 2.0 0.60 2.0 2.0 0.30 1.0 2.0 0.10
Are you embarrassed to go into public places? 1.0 1.0 0.63 1.0 2.0 0.39 1.0 2.0 0.26
Do you put limits on your food choices because of urticaria? 3.0 2.0 0.31 2.0 3.0 0.15 2.5 3.0 0.20
Do you have limits on your physical activity because of urticaria? 0.0 0.0 0.52 0.0 0.0 0.29 0.0 0.0 0.53
Are you affected by side effects from your medications? 0.0 0.0 0.56 0.0 1.0 0.02 0.0 0.0 0.18apallergy.org
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that the Australian group had more severe CIU so reported more 
sleep disturbance. Also, while duration of treatment has been 
documented, we did not document the specific drugs used in 
individuals. If more sedating antihistamines were used by one 
group compared to the other, differences in tiredness may be due 
to this rather than the disease. However, patients in both groups 
ranked side effects from medication as being minimal so this is a 
less likely explanation.
The role of food intolerance in CIU is an area where there may be 
significant culturally driven differences in perception. For instance, 
there is a common belief, based on observation, that hot, spicy 
foods worsen urticaria so it is not surprising that we detected 
a difference between the two patient populations regarding 
limitations on food choices.
There were some gender-based and age-based differences 
noted in QoL. Overall, females from both populations had more 
difficulty with falling asleep. Previous studies have indicated 
that women have a higher prevalence of sleep disturbances 
compared to men and this may account for this finding [9]. Older 
patients were more affected by tiredness and by the side effects 
of medications. Both of these complaints are generally more 
prevalent in aging populations and this may account for the 
differences. Those patients affected by CIU for a longer duration 
were more affected by itch, tiredness due to poor sleep, and 
irritability. Perhaps this is a reflection of disease severity as itch 
can both interfere with the quality of sleep and mood. This also 
illustrates the fact that patients who have this condition for 
a long time do not necessarily ‘get used to it’ or become less 
affected by it.
In conclusion, there are significant differences noted in one 
third of the response to questionnaires between Australian and 
Sri Lankan patient populations with CIU. Some of the differences 
may be explained by differences in cultural perception and 
environmental factors, but variation in disease severity and 
differences in treatment regimens may also contribute in part and 
need further exploration.
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